Shares of Abingdon Health Plc (LON:ABDX – Get Free Report) fell 0.3% on Thursday . The stock traded as low as GBX 10 ($0.13) and last traded at GBX 10.22 ($0.13). 39,218 shares were traded during mid-day trading, a decline of 86% from the average session volume of 272,277 shares. The stock had previously closed at GBX 10.25 ($0.13).
Abingdon Health Price Performance
The company has a current ratio of 1.79, a quick ratio of 1.96 and a debt-to-equity ratio of 55.57. The business has a 50-day moving average price of GBX 10.64 and a 200 day moving average price of GBX 9.66. The stock has a market cap of £12.99 million, a PE ratio of -1,025.00 and a beta of 0.09.
About Abingdon Health
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Recommended Stories
- Five stocks we like better than Abingdon Health
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Technology Stocks Explained: Here’s What to Know About Tech
- MarketBeat Week in Review – 6/24 – 6/28
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
